Evidence map›Paper›PMID 35211125›Full record

ArticleFrontiers in immunology2022

Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.

Kelly L Weaver, Catherine B Blackwood, Alexander M Horspool, Gage M Pyles, Emel Sen-Kilic, Emily M Grayson, Annalisa B Huckaby, William T Witt, Megan A DeJong, M Allison Wolf and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. CD4+ T-cell immunity toDiscover immunity · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clinical microbiology reviews · 2023
    Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Kelly L WeaverDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Catherine B BlackwoodDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Alexander M HorspoolDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Gage M PylesDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Emel Sen-KilicDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Emily M GraysonDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Annalisa B HuckabyDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
William T WittDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Megan A DeJongDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
M Allison WolfDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
F Heath DamronDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
Mariette BarbierDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, United States.
West Virginia University · US

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
Development of mRNA-platform vaccinesR01AI153250 · NIAID · WEST VIRGINIA UNIVERSITY · PI DAMRON, FREDRICK HEATH · 2021 to 2025
$4.1M
Development of mucosal vaccines to protect against pertussisR01AI137155 · NIAID · WEST VIRGINIA UNIVERSITY · PI DAMRON, FREDRICK HEATH · 2019 to 2023
$2.9M
Vaccine Development Against Bacterial Pathogens Based on iron Acquisition ProteinsR01AI141671 · NIAID · WEST VIRGINIA UNIVERSITY · PI BARBIER, MARIETTE · 2019 to 2023
$2.5M
Cell and Molecular Biology Training Program at West Virginia UniversityT32GM133369 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Zoica Cerasela Dinu, MICHAEL D SCHALLER · 2019 to 2026
$2.0M
Special Becton Dickinson Fortessa Flow CytometerS10OD016165 · OD · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2013 to 2013
$384k
NIAID NIH HHS R01 AI137155NIAID NIH HHS R01 AI141671NIAID NIH HHS R01 AI153250NIGMS NIH HHS P20 GM103434NIGMS NIH HHS T32 GM133369NIH HHS S10 OD016165
6 · The paper itself

Abstract

Over two decades ago acellular pertussis vaccines (aP) replaced whole cell pertussis vaccines (wP) in several countries. Since then, a resurgence in pertussis has been observed, which is hypothesized to be linked, in part, to waning immunity. To better understand why waning immunity occurs, we developed a long-term outbred CD1 mouse model to conduct the longest murine pertussis vaccine studies to date, spanning out to 532 days post primary immunization. Vaccine-induced memory results from follicular responses and germinal center formation; therefore, cell populations and cytokines involved with memory were measured alongside protection from challenge. Both aP and wP immunization elicit protection from intranasal challenge by decreasing bacterial burden in both the upper and lower airways, and by generation of pertussis specific antibody responses in mice. Responses to wP vaccination were characterized by a significant increase in T follicular helper cells in the draining lymph nodes and CXCL13 levels in sera compared to aP mice. In addition, a population of

Indexed as

AnimalsAntibodies, BacterialBordetella pertussisChemokine CXCL13Immunization, SecondaryImmunologic MemoryMicePertussis VaccineT Follicular Helper CellsTime FactorsVaccinationWhooping CoughAntibodies, BacterialChemokine CXCL13Pertussis VaccineB memory cellsBordetella pertussisCXCL13germinal centershumoral immunityimmunological memoryTFH cellsvaccine development

Identifiers

PMID35211125
PMCPMC8861382
OpenAlexW4210862593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.